Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/34701
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCorti, R.en
dc.contributor.authorFayad, Z.en
dc.contributor.authorFuster, V.en
dc.contributor.authorWorthley, S.en
dc.contributor.authorHelft, G.en
dc.contributor.authorCheesebro, J.en
dc.contributor.authorMercuri, M.en
dc.contributor.authorBadimon, J.en
dc.date.issued2001en
dc.identifier.citationCirculation, 2001; 104(3):249-252en
dc.identifier.issn0009-7322en
dc.identifier.issn1524-4539en
dc.identifier.urihttp://hdl.handle.net/2440/34701-
dc.description.abstract<h4>Background</h4>This study was designed to investigate the effects of lipid-lowering by simvastatin on human atherosclerotic lesions.<h4>Methods and results</h4>Eighteen asymptomatic hypercholesterolemic patients with documented aortic and/or carotid atherosclerotic plaques were selected for the study. A total of 35 aortic and 25 carotid artery plaques were detected. Serial black-blood MRI of the aorta and carotid artery of the patients was performed at baseline and 6 and 12 months after lipid-lowering therapy with simvastatin. The effects of the treatment on atherosclerotic lesions were measured as changes in lumen area, vessel wall thickness, and vessel wall area, a surrogate of atherosclerotic burden. Simvastatin induced a significant (P<0.01) reduction in total and LDL cholesterol levels at 6 weeks that was maintained thereafter. At 6 months, no changes in lumen area, vessel wall thickness, or vessel wall area were observed. However, at 12 months, significant reductions in vessel wall thickness and vessel wall area, without changes in lumen area, were observed in both aortic and carotid arteries (P<0.001).<h4>Conclusions</h4>This in vivo human study demonstrates that effective and maintained lipid-lowering therapy by simvastatin is associated with a significant regression of atherosclerotic lesions. Our observation suggests that statins induce vascular remodeling, as manifested by reduced atherosclerotic burden without changes in the lumen.en
dc.description.statementofresponsibilityRoberto Corti, Zahi A. Fayad, Valentin Fuster, Stephen G. Worthley, Gerard Helft, James Chesebro, Michele Mercuri, and Juan J. Badimonen
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.rights© 2001 American Heart Association, Inc.en
dc.source.urihttp://circ.ahajournals.org/cgi/content/full/104/3/249en
dc.subjectLipids; atherosclerosis; plaque; magnetic resonance imagingen
dc.titleEffects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imagingen
dc.typeJournal articleen
dc.identifier.rmid0020064339en
dc.identifier.doi10.1161/01.CIR.104.3.249en
dc.identifier.pubid50365-
pubs.library.collectionMedicine publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.